Wednesday, December 14, 2016

BRIEF-Cidara Therapeutics says data from clinical studies support antifungal CD101

* Cidara Therapeutics Inc says data from preclinical and

clinical studies evaluating company's novel echinocandin

antifungal cd101

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)